Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis. (November 2022) - Curtit, E.; Bellanger, M.; Nerich, V.; Hequet, D.; Frenel, J.S.; Cristeau, O.; Rouzier, R.